YOKNEAM ILLIT, Israel, April 3, 2025 /PRNewswire/ -- Israeli startup ProFuse Technology, which specializes in the cultivation of muscle tissue in laboratory…
Membership will bolster the ranks of academic and community hospitals joining the Ryght Research Network to streamline clinical trials with…
New Survey Reveals 30% of Middle-Aged Women are Embracing Sober Curiosity as 45% Express Dependency Concerns DENVER, April 3, 2025…
Presession focused on MDS/MPN-related anemia. Participants can register for the presession and SOHO 2025 at soho.click/2025 . HOUSTON, April 3, 2025…
New data to be presented from Company’s lead product candidate SENTI-202 for the treatment of relapsed/refractory acute myeloid leukemia (r/r…
ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on…
Comes on the heels of company’s rebranding and new strategic direction, advancing its lead program in ovarian cancerCAMBRIDGE, Mass., April…
THE WOODLANDS, TX, April 03, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device…
Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal condition affecting five to…
STAFFORD, Texas, April 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…